z-logo
Premium
Efficacy of a psychological online intervention for depression in people with epilepsy: A randomized controlled trial
Author(s) -
Schröder Johanna,
Brückner Katja,
Fischer Anja,
Lindenau Matthias,
Köther Ulf,
Vettorazzi Eik,
Moritz Steffen
Publication year - 2014
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/epi.12833
Subject(s) - randomized controlled trial , beck depression inventory , depression (economics) , epilepsy , quality of life (healthcare) , psychological intervention , psychology , psychiatry , major depressive disorder , intervention (counseling) , clinical psychology , medicine , anxiety , psychotherapist , cognition , economics , macroeconomics
Summary Objective Depression is the most prevalent psychiatric disorder in persons with epilepsy ( PWE s). Despite its major impact on quality of life and risk of suicide, most PWE s are not treated for depression. A current challenge in mental health care is how to close this treatment gap and increase access to psychological services. Psychological online interventions ( POI s) have shown efficacy in improving depression among individuals without neurologic disorders. This pilot study aimed to assess the feasibility and efficacy of a psychological online intervention for depression (Deprexis) in PWE s who have symptoms of depression. Methods Participants with self‐reported epilepsy and subjective complaints of depressive symptoms were randomized to an intervention condition (Deprexis) or to a waiting list control ( WLC ) condition. After 9 weeks, participants were invited to complete an online reassessment. Results Relative to the waiting list group, program users experienced a significant symptom decline on the Beck Depression Inventory ‐ I ( BDI ‐I, primary outcome) with a moderate effect size in the complete observations analysis and a small effect size in the intention‐to‐treat analysis. Furthermore, there was a significant improvement with a moderate effect size on the “energy/fatigue” subscale of the Quality of Life In Epilepsy Inventory ‐ 31 ( QOLIE ‐31). Significance The results of this trial suggest that POI s may be a feasible and beneficial tool for PWE s who have comorbid depressive symptoms.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom